Trial intelligence / Profile preview

Prophylactic Noradrenaline for Post-induction Hypotension in Sepsis

NCT07022730Completed

Sponsor
Cairo University
Start
Jun 2025
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of norepinephrine in hypotension (2 arms), sponsored by Cairo University. Primary endpoint: Incidence of post induction hypotension at 10 minutes. Started Jun 2025; status: completed.

02

Drugs

norepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on NCT07022730.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07022730.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call